The global enzyme replacement therapy market is witnessing steady growth, driven by the rising prevalence of lysosomal storage diseases and increasing regulatory approvals for treatments targeting rare disorders. The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028. The market is estimated to register a compound annual...